Citius pharmaceuticals, inc. and its cfo & cbo jaime bartushak honored by somerset hills learning institute

Leading center for autism education and research has named citius and bartushak the 2022 honorees for their annual halloween gala cranford, n.j. , sept. 15, 2022 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, today announced that citius, along with the company's chief financial officer and chief business officer, jaime bartushak, were named as 2022 honorees by the somerset hills learning institute ("the institute").
CTXR Ratings Summary
CTXR Quant Ranking